Huang K, Yang T, Xu J, Yang L, Zhao J, Zhang X, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019;394:407–18.
O’Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, et al. Inhaled combined budesonide-formoterol as needed in mild asthma. N Engl J Med. 2018;378:1865–76.
Bateman ED, Reddel HK, O’Byrne PM, Barnes PJ, Zhong N, Keen C, et al. As-needed budesonide-formoterol versus maintenance budesonide in mild asthma. N Engl J Med. 2018;378:1877–87.
Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181:315–23.
Rajvanshi N, Kumar P, Goyal JP. Global Initiative for Asthma Guidelines 2024: an update. Indian Pediatr. 2024;61:781–6.
Mao Z, Zhu X, Zheng P, Wang L, Zhang F, Chen L, et al. Global, regional, and national burden of asthma from 1990 to 2021: a systematic analysis of the Global Burden of Disease Study 2021. Chin Med J Pulm Crit Care Med. 2025;3:50–9.
Denlinger LC, Heymann P, Lutter R, Gern JE. Exacerbation-prone asthma. J Allergy Clin Immunol Pract. 2020;8:474–82.
Jartti T, Gern JE. Role of viral infections in the development and exacerbation of asthma in children. J Allergy Clin Immunol. 2017;140:895–906.
Makrinioti H, Hasegawa K, Lakoumentas J, Xepapadaki P, Tsolia M, Castro-Rodriguez JA, et al. The role of respiratory syncytial virus- and rhinovirus-induced bronchiolitis in recurrent wheeze and asthma-a systematic review and meta-analysis. Pediatr Allergy Immunol. 2022;33:e13741.
Iyadorai T, Wong PL, Sii HL, P’Ng CK, Ee SS, Tan MP, et al. Respiratory symptoms and health outcomes of rhinovirus and influenza virus infections: implications of asthma, diabetes mellitus and allergic rhinitis in rhinovirus C infection. J Med Virol. 2025;97:e70281.
Kohlmeier JE, Woodland DL. Immunity to respiratory viruses. Annu Rev Immunol. 2009;27:61–82.
Gaberino CL, Altman MC, Gill MA, Bacharier LB, Gruchalla RS, O’Connor GT, et al. Dysregulation of airway and systemic interferon responses promotes asthma exacerbations in urban children. J Allergy Clin Immunol. 2025;155:1499–1509.
Jazaeri S, Goldsmith AM, Jarman CR, Lee J, Hershenson MB, Lewis TC. Nasal interferon responses to community rhinovirus infections are similar in controls and children with asthma. Ann Allergy Asthma Immunol. 2021;126:690–5 e1.
Farne H, Lin L, Jackson DJ, Rattray M, Simpson A, Custovic A, et al. In vivo bronchial epithelial interferon responses are augmented in asthma on day 4 following experimental rhinovirus infection. Thorax. 2022;77:929–32.
Rich HE, Antos D, Melton NR, Alcorn JF, Manni ML. Insights into type I and III interferons in asthma and exacerbations. Front Immunol. 2020;11:574027.
McDowell PJ, Busby J, Hanratty CE, Djukanovic R, Woodcock A, Walker S, et al. Exacerbation profile and risk factors in a type-2-low enriched severe asthma cohort: a clinical trial to assess asthma exacerbation phenotypes. Am J Respir Crit Care Med. 2022;206:545–53.
Just J, Bourgoin-Heck M, Amat F. Clinical phenotypes in asthma during childhood. Clin Exp Allergy. 2017;47:848–55.
Mishra PE, Melen E, Koppelman GH, Celedon JC. T2-low asthma in school-aged children: unacknowledged and understudied. Lancet Respir Med. 2023;11:1044–5.
Johansson C, Kirsebom FCM. Neutrophils in respiratory viral infections. Mucosal Immunol. 2021;14:815–27.
Warren KJ, Poole JA, Sweeter JM, DeVasure JM, Dickinson JD, Peebles RS Jr, et al. Neutralization of IL-33 modifies the type 2 and type 3 inflammatory signature of viral induced asthma exacerbation. Respir Res. 2021;22:206.
Liu X, Netto KG, Sokulsky LA, Zhou L, Xu H, Liu C, et al. Single-cell RNA transcriptomic analysis identifies Creb5 and CD11b-DCs as regulator of asthma exacerbations. Mucosal Immunol. 2022;15:1363–74.
Hou F, Xiao K, Tang L, Xie L. Diversity of macrophages in lung homeostasis and diseases. Front Immunol. 2021;12:753940.
Kulikauskaite J, Wack A. Teaching old dogs new tricks? The plasticity of lung alveolar macrophage subsets. Trends Immunol. 2020;41:864–77.
Xu X, Xu JF, Zheng G, Lu HW, Duan JL, Rui W, et al. CARD9(S12N) facilitates the production of IL-5 by alveolar macrophages for the induction of type 2 immune responses. Nat Immunol. 2018;19:547–60.
Yu S, Leung KM, Kim HY, Umetsu SE, Xiao Y, Albacker LA, et al. Blockade of RGMb inhibits allergen-induced airways disease. J Allergy Clin Immunol. 2019;144:94–108 e11.
Saradna A, Do DC, Kumar S, Fu QL, Gao P. Macrophage polarization and allergic asthma. Transl Res. 2018;191:1–14.
Yuan L, Qin Q, Yao Y, Chen L, Liu H, Du X, et al. Increased expression of cathepsin C in airway epithelia exacerbates airway remodeling in asthma. JCI Insight. 2024;9:e181219.
Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumor metastasis. Nature. 2011;475:222–5.
Hume DA, MacDonald KP. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood. 2012;119:1810–20.
Sajti E, Link VM, Ouyang Z, Spann NJ, Westin E, Romanoski CE, et al. Transcriptomic and epigenetic mechanisms underlying myeloid diversity in the lung. Nat Immunol. 2020;21:221–31.
Khaket TP, Singh MP, Khan I, Kang SC. In vitro and in vivo studies on potentiation of curcumin-induced lysosomal-dependent apoptosis upon silencing of cathepsin C in colorectal cancer cells. Pharmacol Res. 2020;161:105156.
Sorensen OE, Clemmensen SN, Dahl SL, Ostergaard O, Heegaard NH, Glenthoj A, et al. Papillon-Lefevre syndrome patient reveals species-dependent requirements for neutrophil defenses. J Clin Invest. 2014;124:4539–48.
Korkmaz B, Jaillet J, Jourdan ML, Gauthier A, Gauthier F, Attucci S. Catalytic activity and inhibition of Wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils. J Biol Chem. 2009;284:19896–902.
Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol. 2006;177:7303–11.
Cheung P, Schaffert S, Chang SE, Dvorak M, Donato M, Macaubas C, et al. Repression of CTSG, ELANE and PRTN3-mediated histone H3 proteolytic cleavage promotes monocyte-to-macrophage differentiation. Nat Immunol. 2021;22:711–22.
Kantari C, Millet A, Gabillet J, Hajjar E, Broemstrup T, Pluta P, et al. Molecular analysis of the membrane insertion domain of proteinase 3, the Wegener’s autoantigen, in RBL cells: implication for its pathogenic activity. J Leukoc Biol. 2011;90:941–50.
Scott IC, Majithiya JB, Sanden C, Thornton P, Sanders PN, Moore T, et al. Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage. Sci Rep. 2018;8:3363.
Zhang GP, Yue X, Li SQ. Cathepsin C interacts with TNF-alpha/p38 MAPK signaling pathway to promote proliferation and metastasis in hepatocellular carcinoma. Cancer Res Treat. 2020;52:10–23.
Alam S, Liu Q, Liu S, Liu Y, Zhang Y, Yang X, et al. Upregulated cathepsin C induces macrophage M1 polarization through FAK-triggered p38 MAPK/NF-kappaB pathway. Exp Cell Res. 2019;382:111472.
Zhao X, Liu S, Yang X, Liu Y, Liu G, Fan K, et al. Cathepsin C aggravates neuroinflammation by promoting production of CCL2 and CXCL2 in glial cells and neurons in a cryogenic brain lesion. Neurochem Int. 2021;148:105107.
Openshaw PJM, Chiu C, Culley FJ, Johansson C. Protective and harmful immunity to RSV infection. Annu Rev Immunol. 2017;35:501–32.
Warner SM, Wiehler S, Michi AN, Proud D. Rhinovirus replication and innate immunity in highly differentiated human airway epithelial cells. Respir Res. 2019;20:150.
Aiello S, Benigni A, Remuzzi G. Tissue-resident macrophages in solid organ transplantation: Harmful or protective? J Immunol. 2024;212:1051–61.
Zhao J, Andreev I, Silva HM. Resident tissue macrophages: key coordinators of tissue homeostasis beyond immunity. Sci Immunol. 2024;9:eadd1967.
Cao M, Wang Z, Lan W, Xiang B, Liao W, Zhou J, et al. The roles of tissue resident macrophages in health and cancer. Exp Hematol Oncol. 2024;13:3.
Wang YF, Zhang WL, Li ZX, Liu Y, Tan J, Yin HZ, et al. METTL14 downregulation drives S100A4(+) monocyte-derived macrophages via MyD88/NF-kappaB pathway to promote MAFLD progression. Signal Transduct Target Ther. 2024;9:91.
Schwab AD, Wyatt TA, Moravec G, Thiele GM, Nelson AJ, Gleason A, et al. Targeting transitioning lung monocytes/macrophages as treatment strategies in lung disease related to environmental exposures. Respir Res. 2024;25:157.
Ju X, Fard NE, Bhalla A, Dvorkin-Gheva A, Xiao M, Radford K, et al. A population of c-kit(+) IL-17A(+) ILC2s in sputum from individuals with severe asthma supports ILC2 to ILC3 trans-differentiation. Sci Transl Med. 2025;17:eado6649.
Kotrba J, Muller I, Pausder A, Hoffmann A, Camp B, Boehme JD, et al. Innate players in Th2 and non-Th2 asthma: emerging roles for the epithelial cell, mast cell, and monocyte/macrophage network. Am J Physiol Cell Physiol. 2024;327:C1373–C83.
Misharin AV, Morales-Nebreda L, Reyfman PA, Cuda CM, Walter JM, McQuattie-Pimentel AC, et al. Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span. J Exp Med. 2017;214:2387–404.
van de Laar L, Saelens W, De Prijck S, Martens L, Scott CL, Van Isterdael G, et al. Yolk sac macrophages, fetal liver, and adult monocytes can colonize an empty niche and develop into functional tissue-resident macrophages. Immunity. 2016;44:755–68.
Gibbings SL, Goyal R, Desch AN, Leach SM, Prabagar M, Atif SM, et al. Transcriptome analysis highlights the conserved difference between embryonic and postnatal-derived alveolar macrophages. Blood. 2015;126:1357–66.
Herias V, Biessen EA, Beckers C, Delsing D, Liao M, Daemen MJ, et al. Leukocyte cathepsin C deficiency attenuates atherosclerotic lesion progression by selective tuning of innate and adaptive immune responses. Arterioscler Thromb Vasc Biol. 2015;35:79–86.
Badorrek P, Diefenbach C, Kogler H, Eleftheraki A, Seitz F, Hohlfeld JM. Novel cathepsin C inhibitor, BI 1291583, intended for treatment of bronchiectasis: phase I characterization in healthy volunteers. Clin Transl Sci. 2024;17:e13891.
Gunsolley JC, Chalmers JD, Sibila O, Fernandez C, Scannapieco FA. Periodontal effects of the reversible dipeptidyl peptidase 1 inhibitor brensocatib in bronchiectasis. JDR Clin Trans Res. 2024;9:277–85.
Chalmers JD, Shteinberg M, Mall MA, O’Donnell AE, Watz H, Gupta A, et al. Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomized, double-blind, placebo-controlled, dose-finding study. Eur Respir J. 2025;65:2401551.
Chitsamankhun C, Siritongtaworn N, Fournier BPJ, Sriwattanapong K, Theerapanon T, Samaranayake L, et al. Cathepsin C in health and disease: from structural insights to therapeutic prospects. J Transl Med. 2024;22:777.
Laoui D, Van Overmeire E, Abels C, Keirsse J, Van Ginderachter JA. Adoptive transfer of monocytes sorted from bone marrow. Bio Protoc. 2019;9:e3134.
Liu C, Xiang Y, Liu HJ, Gao G, Howard ST, Zhu XL, et al. Involvement of integrin beta4 in ozone stress-induced airway hyperresponsiveness. Biochem Biophys Res Commun. 2010;397:290–5.
Lynch JP, Werder RB, Simpson J, Loh Z, Zhang V, Haque A, et al. Aeroallergen-induced IL-33 predisposes to respiratory virus-induced asthma by dampening antiviral immunity. J Allergy Clin Immunol. 2016;138:1326–37.
Sun L, Zhang H, Zhang H, Lou X, Wang Z, Wu Y, et al. Staphylococcal virulence factor HlgB targets the endoplasmic-reticulum-resident E3 ubiquitin ligase AMFR to promote pneumonia. Nat Microbiol. 2023;8:107–20.
Du X, Yang Y, Xiao G, Yang M, Yuan L, Qin L, et al. Respiratory syncytial virus infection-induced mucus secretion by downregulation of miR-34b/c-5p expression in airway epithelial cells. J Cell Mol Med. 2020;24:12694–705.
Li W, Du X, Yang Y, Yuan L, Yang M, Qin L, et al. miRNA-34b/c regulates mucus secretion in RSV-infected airway epithelial cells by targeting FGFR1. J Cell Mol Med. 2021;25:10565–74.
Du X, Yuan L, Yao Y, Yang Y, Zhou K, Wu X, et al. ITGB4 deficiency in airway epithelium aggravates RSV infection and increases HDM sensitivity. Front Immunol. 2022;13:912095.